Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for FitLife Brands Inc. (FTLF : OTC)

• Company Description    FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. Number of Employees: 23

• Price / Volume Information    Yesterday's Closing Price: $10.55 Daily Weekly Monthly 20 Day Moving Average: 3,195 shares Shares Outstanding: 4.56 (millions) Market Capitalization: $48.07 (millions) Beta: 1.29 52 Week High: $16.85 52 Week Low: $7.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.45% 10.99% 12 Week -24.64% -17.16% Year To Date -34.06% -19.43%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5214 S. 136TH STREET - OMAHA,NE 68137 USA ph: 402-991-5618 fax: - dmossberg@threepa.com http://www.fitlifebrands.com

• General Corporate Information    Officers Dayton Judd - Chief Executive Officer and Chairman of the Board Susan Kinnaman - Chief Financial Officer Grant Dawson - Director Lewis Jaffe - Director Todd Ordal - Director Peer Information FitLife Brands Inc. (BJCT) FitLife Brands Inc. (CADMQ) FitLife Brands Inc. (APNO) FitLife Brands Inc. (UPDC) FitLife Brands Inc. (IMTIQ) FitLife Brands Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 33817P306 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/21 Next Expected EPS Date: 05/20/22 Share - Related Items Shares Outstanding: 4.56 Most Recent Split Date: 12.00 (4.00:1) Beta: 1.29 Market Capitalization: $48.07 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/20/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 8.74 PEG Ratio: - Price Ratios Price/Book: 3.48 Price/Cash Flow: 10.32 Price / Sales: 1.78 EPS Growth vs. Year Ago Period: -35.86% vs. Previous Quarter: -26.19% Sales Growth vs. Year Ago Period: -3.15% vs. Previous Quarter: -17.64% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - 39.94 ROA 03/31/22 - - 12/31/21 - - 09/30/21 - 30.18 Current Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - 3.75 Quick Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - 2.38 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - 21.23 Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - 37.31 Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - 24.91 Book Value 03/31/22 - - 12/31/21 - - 09/30/21 - 3.03 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - 3.12 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - 0.00

Powered by Zacks Investment Research ©